Digestive Diseases and Sciences

, Volume 59, Issue 12, pp 2874–2889 | Cite as

Risk Factors for Serrated Polyps of the Colorectum

  • Tanvir R. Haque
  • Patrick T. Bradshaw
  • Seth D. Crockett
Review

Abstract

Serrated pathway polyps are a relatively new area of interest in the field of colorectal cancer screening and prevention. Akin to conventional adenomas, some serrated polyps (SPs) have the potential to develop into malignant serrated neoplasms, yet little is known regarding risk factors for these lesions. Early epidemiological studies of hyperplastic polyps were performed without knowledge of the serrated pathway and likely included a mixture of SPs. More recently, studies have specifically evaluated premalignant SPs, such as the sessile serrated adenoma (SSA) or surrogates for these polyps such as large or proximally located SPs. SPs share some risk factors with conventional adenomas and have been associated with tobacco use, obesity, and age. Nonsteroidal anti-inflammatory drug (NSAID) use, fiber, folic acid, and calcium have been associated with reduced risk of SPs. Studies focused on SSAs specifically have reported associations with age, female sex, smoking, obesity, diabetes, and possibly diets high in fat, carbohydrates, and calories. Higher education has also been associated with risk of SSAs, while an inverse association between NSAID use and SSAs has been reported. Risk factors for traditional serrated adenomas are largely unknown. Studies are largely limited by varying inclusion criteria, as well as differences in pathological classification schemes. Further epidemiological studies of SPs are needed to aid in risk stratification and screening, and etiological research.

Keywords

Colonic neoplasms (MeSH) Colonic polyps (MeSH) Epidemiology (MeSH) Sessile serrated adenoma Hyperplastic polyp Traditional serrated adenoma 

Notes

Acknowledgments

This work was supported, in part, by a grant from the American College of Gastroenterology, ACG-JR-000-2012 (SDC), and a grant from the National Institutes of Health, K12-CA120780 (PTB).

Conflict of interest

None.

Supplementary material

10620_2014_3277_MOESM1_ESM.pdf (125 kb)
Supplementary material 1 (PDF 125 kb)
10620_2014_3277_MOESM2_ESM.pdf (166 kb)
Supplementary material 2 (PDF 166 kb)
10620_2014_3277_MOESM3_ESM.pdf (176 kb)
Supplementary material 3 (PDF 175 kb)

References

  1. 1.
    Morson B. Some peculiarities in the histology of intestinal polyps. Dis Colon Rectum. 1962;5:337–344.CrossRefGoogle Scholar
  2. 2.
    Oka S, Tanaka S, Hiyama T, et al. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc. 2004;59:213–219.PubMedCrossRefGoogle Scholar
  3. 3.
    Huang CS, Farraye FA, Yang S, et al. The clinical significance of serrated polyps. Am J Gastroenterol. 2011;106:229–240; quiz 241.Google Scholar
  4. 4.
    Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144:74 e1–80 e1.Google Scholar
  5. 5.
    Hetzel JT, Huang CS, Coukos JA, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010;105:2656–2664.PubMedCrossRefGoogle Scholar
  6. 6.
    Kahi CJ, Hewett DG, Norton DL, et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9:42–46.PubMedCrossRefGoogle Scholar
  7. 7.
    Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006;131:1700–1705.PubMedCrossRefGoogle Scholar
  8. 8.
    Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol. 2010;8:858–864.PubMedCrossRefGoogle Scholar
  9. 9.
    Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010;105:1189–1195.PubMedCrossRefGoogle Scholar
  10. 10.
    O’Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491–1501.PubMedCrossRefGoogle Scholar
  11. 11.
    Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–1105.PubMedCrossRefGoogle Scholar
  12. 12.
    Crockett SD, Snover DC, Ahnen DJ, et al. Sessile serrated adenomas: an evidence-based guide to management. Clin Gastroenterol Hepatol. 2013;. doi:10.1016/j.cgh.2013.10.035.PubMedGoogle Scholar
  13. 13.
    Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology. 2010;139:1497–1502.PubMedCrossRefGoogle Scholar
  14. 14.
    Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.PubMedCrossRefGoogle Scholar
  15. 15.
    Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532.PubMedCrossRefGoogle Scholar
  16. 16.
    Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524–537.PubMedCrossRefGoogle Scholar
  17. 17.
    East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am. 2008;37:25-46, v.Google Scholar
  18. 18.
    Lee EJ, Choi C, Park CK, et al. Tracing origin of serrated adenomas with BRAF and KRAS mutations. Virchows Arch. 2005;447:597–602.PubMedCrossRefGoogle Scholar
  19. 19.
    Torlakovic E, Skovlund E, Snover DC, et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65–81.PubMedCrossRefGoogle Scholar
  20. 20.
    Miwa S, Mitomi H, Igarashi M, et al. Clinicopathologic differences among subtypes of serrated adenomas of the colorectum. Hepatogastroenterology. 2005;52:437–440.PubMedGoogle Scholar
  21. 21.
    Sawyer EJ, Cerar A, Hanby AM, et al. Molecular characteristics of serrated adenomas of the colorectum. Gut. 2002;51:200–206.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours pathology and genetics. In: Tumours of the Digestive System. 4th ed. Berlin: Springer; 2010.Google Scholar
  24. 24.
    Carr NJ, Mahajan H, Tan KL, et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62:516–518.PubMedCrossRefGoogle Scholar
  25. 25.
    Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131:1400–1407.PubMedCrossRefGoogle Scholar
  26. 26.
    Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63:681–686.PubMedCrossRefGoogle Scholar
  27. 27.
    Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–1329; quiz 1314, 1330.Google Scholar
  29. 29.
    Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778–796.PubMedCrossRefGoogle Scholar
  30. 30.
    Weston AP, Campbell DR. Diminutive colonic polyps: histopathology, spatial distribution, concomitant significant lesions, and treatment complications. Am J Gastroenterol. 1995;90:24–28.PubMedGoogle Scholar
  31. 31.
    Tedesco FJ, Hendrix JC, Pickens CA, et al. Diminutive polyps: histopathology, spatial distribution, and clinical significance. Gastrointest Endosc. 1982;28:1–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Lambert R, Kudo SE, Vieth M, et al. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc. 2009;70:1182–1199.PubMedCrossRefGoogle Scholar
  33. 33.
    Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290:2959–2967.PubMedCrossRefGoogle Scholar
  34. 34.
    O’Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am. 2007;36:947–968, viii.Google Scholar
  35. 35.
    O’Brien MJ, Yang S, Clebanoff JL, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28:423–434.PubMedCrossRefGoogle Scholar
  36. 36.
    Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol. 2006;125:132–145.PubMedCrossRefGoogle Scholar
  37. 37.
    Oh K, Redston M, Odze RD. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol. 2005;36:101–111.PubMedCrossRefGoogle Scholar
  38. 38.
    Fu B, Yachida S, Morgan R, et al. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol. 2012;138:356–366.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Limketkai BN, Lam-Himlin D, Arnold CA, et al. The cutting edge of serrated polyps: a practical guide to approaching and managing serrated colon polyps. Gastrointest Endosc. 2013;77:360–375.PubMedCrossRefGoogle Scholar
  40. 40.
    Torlakovic EE, Gomez JD, Driman DK, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32:21–29.PubMedCrossRefGoogle Scholar
  41. 41.
    Martinez ME, McPherson RS, Levin B, et al. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology. 1997;113:423–429.PubMedCrossRefGoogle Scholar
  42. 42.
    Erhardt JG, Kreichgauer HP, Meisner C, et al. Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps—a case control study. Eur J Nutr. 2002;41:35–43.PubMedCrossRefGoogle Scholar
  43. 43.
    Ji B-T, Weissfeld JL, Chow W-H, et al. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. Am Soc Prev Oncol. 2006;15:897–901.Google Scholar
  44. 44.
    Kearney J, Giovannucci E, Rimm EB, et al. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control. 1995;6:45–56.PubMedCrossRefGoogle Scholar
  45. 45.
    Morimoto LM, Newcomb PA, Ulrich CM, et al. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. Am Soc Prev Oncol. 2002;11:1012–1018.Google Scholar
  46. 46.
    Omata F, Brown WR, Tokuda Y, et al. Modifiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med. 2009;48:123–128.PubMedCrossRefGoogle Scholar
  47. 47.
    Shrubsole MJ, Wu H, Ness RM, et al. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol. 2008;167:1050–1058.PubMedCrossRefGoogle Scholar
  48. 48.
    Burnett-Hartman AN, Passarelli MN, Adams SV, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol. 2013;177:625–637.PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Anderson JC, Rangasamy P, Rustagi T, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol. 2011;45:694–699.PubMedCrossRefGoogle Scholar
  50. 50.
    Heitman SJ, Ronksley PE, Hilsden RJ, et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1272–1278.PubMedCrossRefGoogle Scholar
  51. 51.
    Bouwens MW, Winkens B, Rondagh EJ, et al. Simple clinical risk score identifies patients with serrated polyps in routine practice. Cancer Prev Res (Phila). 2013;6:855–863.CrossRefGoogle Scholar
  52. 52.
    Wallace K, Grau MV, Ahnen D, et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev. 2009;18:2310–2317.PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–174.PubMedCrossRefGoogle Scholar
  54. 54.
    Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061–2068.PubMedCrossRefGoogle Scholar
  55. 55.
    Rex DK. Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol. 1995;90:353–365.PubMedGoogle Scholar
  56. 56.
    Min YW, Lee JH, Lee SH, et al. Prevalence of proximal colon serrated polyps in a population at average risk undergoing screening colonoscopy: a multicenter study. Clin Res Hepatol Gastroenterol. 2012;36:604–608.PubMedCrossRefGoogle Scholar
  57. 57.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.PubMedCrossRefGoogle Scholar
  58. 58.
    Lieberman DA, Holub JL, Moravec MD, et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417–1422.PubMedCrossRefGoogle Scholar
  59. 59.
    Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139:1503–1510, 1510 e1–1513 e1.Google Scholar
  60. 60.
    Fu Z, Shrubsole MJ, Smalley WE, et al. Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol. 2012;176:766–776.PubMedCentralPubMedCrossRefGoogle Scholar
  61. 61.
    Miller PE, Lesko SM, Muscat JE, et al. Dietary patterns and colorectal adenoma and cancer risk: a review of the epidemiological evidence. Nutr Cancer. 62:413–424.Google Scholar
  62. 62.
    Giovannucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327–334.PubMedCrossRefGoogle Scholar
  63. 63.
    Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–1638.PubMedCrossRefGoogle Scholar
  64. 64.
    Martinez ME, Giovannucci E, Spiegelman D, et al. Leisure-time physical activity, body size, and colon cancer in women. Nurses’ Health Study Research Group. J Natl Cancer Inst. 1997;89:948–955.PubMedCrossRefGoogle Scholar
  65. 65.
    Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142:762–772.PubMedCrossRefGoogle Scholar
  66. 66.
    Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739–750.PubMedCrossRefGoogle Scholar
  67. 67.
    Wish TA, Hyde AJ, Parfrey PS, et al. Increased cancer predisposition in family members of colorectal cancer patients harboring the p. V600E BRAF mutation: a population-based study. Cancer Epidemiol Biomarkers Prev. 2010;19:1831–1839.PubMedCrossRefGoogle Scholar
  68. 68.
    Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L, et al. Somatic BRAF-V600E mutations in familial colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:2270–2273.PubMedCrossRefGoogle Scholar
  69. 69.
    Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2012;62:404–408.PubMedCentralPubMedCrossRefGoogle Scholar
  70. 70.
    Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 1996;110:748–755.PubMedCrossRefGoogle Scholar
  71. 71.
    Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832–841.PubMedCentralPubMedCrossRefGoogle Scholar
  72. 72.
    Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007;133:1077–1085.PubMedCrossRefGoogle Scholar
  73. 73.
    Bensen SP, Cole BF, Mott LA, et al. Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Lancet. 1999;354:1873–1874.PubMedCrossRefGoogle Scholar
  74. 74.
    Burnett-Hartman AN, Newcomb PA, Potter JD, et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 2013;73:2863–2872.PubMedCrossRefGoogle Scholar
  75. 75.
    Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol. 2012;47:178–183.PubMedCrossRefGoogle Scholar
  76. 76.
    Boyle T, Keegel T, Bull F, et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104:1548–1561.PubMedCrossRefGoogle Scholar
  77. 77.
    Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer. 2011;104:882–885.PubMedCentralPubMedCrossRefGoogle Scholar
  78. 78.
    Yuhara H, Steinmaus C, Cohen SE, et al. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011;106:1911–1921; quiz 1922.Google Scholar
  79. 79.
    Eddi R, Karki A, Shah A, et al. Association of type 2 diabetes and colon adenomas. J Gastrointest Cancer. 2012;43:87–92.PubMedCrossRefGoogle Scholar
  80. 80.
    Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350:991–1004.PubMedCrossRefGoogle Scholar
  81. 81.
    Bossard C, Denis MG, Bezieau S, et al. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep. 2007;18:1093–1097.PubMedGoogle Scholar
  82. 82.
    Klarskov L, Mogensen AM, Jespersen N, et al. Filiform serrated adenomatous polyposis arising in a diverted rectum of an inflammatory bowel disease patient. APMIS. 2011;119:393–398.PubMedCrossRefGoogle Scholar
  83. 83.
    Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2013;62:404–408.PubMedCentralPubMedCrossRefGoogle Scholar
  84. 84.
    Rosty C, Hewett DG, Brown IS, et al. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol. 2013;48:287–302.PubMedCentralPubMedCrossRefGoogle Scholar
  85. 85.
    Ogino S, Lochhead P, Chan AT, et al. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013;26:465–484.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Tanvir R. Haque
    • 1
  • Patrick T. Bradshaw
    • 2
  • Seth D. Crockett
    • 1
  1. 1.Division of Gastroenterology and HepatologyUniversity of North Carolina School of MedicineChapel HillUSA
  2. 2.Department of Epidemiology, Gillings School of Global Public HealthUniversity of North CarolinaChapel HillUSA

Personalised recommendations